|
Overview
Monoclonal antibodies are quickly becoming key resources in the therapeutic, diagnostic and drug discovery
fields. With the phenomenal growth in the market for monoclonal antibodies, it becomes even
more critical to explore diverse methods of design, production and application of technologies to provide
the antibodies needed. This conference will provide researchers with key updates on important
developments in the monoclonal antibody field covering generation, optimization, therapeutics, drug
discovery research and in vivo diagnostics.
|
Topics may include, but are not limited to:
|
|
• Pharmaceutical/drug discovery applications
• Successful therapeutic case studies
• Target characterization and validation
• Novel expression methods
• Improving safety of therapeutics
• Improving mAb characteristics
|
• Optimizing yields
• Novel immunization methods (like cDNA)
• Use of different species for fusion/new
fusion partner cell lines
• Antibodies to signaling proteins/Phospho-specific antibodies |
Researchers are encouraged to submit a title and 3-5 sentence summary for consideration for oral and
poster presentations. Please include the complete contact information for the proposed presenter.
Click
here to submit a proposal
For more information, please contact, fax or e-mail submissions to:
Elizabeth Lamb, Senior Conference Director, Cambridge Healthtech Institute
Fax: 207-493-7874 • E-mail: elamb@healthtech.com
For exhibits and sponsorship information, please contact:
Carol Dinerstein, Manager of Business Development • Phone: 781-972-5471
• E-mail: dinerstein@healthtech.com
|
